Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Smith

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Molecular Imaging|September 7, 2006
In vivo monitoring of pancreatic beta-cells in a transgenic mouse modelSteven J Smith, Hongbing Zhang, Anne O Clermont, et al.
Current Topics in Medicinal Chemistry|August 14, 2015
6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase InhibitorsXue Zhi Zhao, Mathieu Metifiot, Steven J Smith, et al.
Journal of Medicinal Chemistry|June 6, 2014
4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1Xue Zhi Zhao, Steven J Smith, Mathieu Métifiot, et al.
Environment International|February 2, 2020
Health co-benefits and mitigation costs as per the Paris Agreement under different technological pathways for energy supplyJon Sampedro, Steven J Smith, Iñaki Arto, et al.
Frontiers in Cardiovascular Medicine|January 28, 2026
Case Report: Neuropsychiatric improvement after treatment of pelvic venous disorder in a multisyndromic patientSteven J Smith, Michael J Sichlau, Peter C Rowe, et al.
Journal of Medicinal Chemistry|January 30, 2014
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutantsXue Zhi Zhao, Steven J Smith, Mathieu Métifiot, et al.
Journal of Virology|April 13, 2018
Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse TranscriptasePaul L Boyer, Steven J Smith, Xue Zhi Zhao, et al.
NAR Molecular Medicine|December 22, 2025
Pi-pi stacking interactions with viral DNA contribute to the potency of naphthyridine-based HIV-1 integrase inhibitorsXue Zhi Zhao, Min Li, Steven J Smith, et al.
ACS Infectious Diseases|March 9, 2021
HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase MutantsSteven J Smith, Xue Zhi Zhao, Dario Oliveira Passos, et al.
Atmospheric Chemistry and Physics|November 18, 2020
Interannual variability and trends of combustion aerosol and dust in major continental outflows revealed by MODIS retrievals and CAM5 simulations during 2003-2017Hongbin Yu, Yang Yang, Hailong Wang, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Molecular Imaging|September 7, 2006
In vivo monitoring of pancreatic beta-cells in a transgenic mouse modelSteven J Smith, Hongbing Zhang, Anne O Clermont, et al.
Current Topics in Medicinal Chemistry|August 14, 2015
6,7-Dihydroxyisoindolin-1-one and 7,8-Dihydroxy-3,4-Dihydroisoquinolin- 1(2H)-one Based HIV-1 Integrase InhibitorsXue Zhi Zhao, Mathieu Metifiot, Steven J Smith, et al.
Journal of Medicinal Chemistry|June 6, 2014
4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1Xue Zhi Zhao, Steven J Smith, Mathieu Métifiot, et al.
Environment International|February 2, 2020
Health co-benefits and mitigation costs as per the Paris Agreement under different technological pathways for energy supplyJon Sampedro, Steven J Smith, Iñaki Arto, et al.
Frontiers in Cardiovascular Medicine|January 28, 2026
Case Report: Neuropsychiatric improvement after treatment of pelvic venous disorder in a multisyndromic patientSteven J Smith, Michael J Sichlau, Peter C Rowe, et al.
Journal of Medicinal Chemistry|January 30, 2014
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutantsXue Zhi Zhao, Steven J Smith, Mathieu Métifiot, et al.
Journal of Virology|April 13, 2018
Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse TranscriptasePaul L Boyer, Steven J Smith, Xue Zhi Zhao, et al.
NAR Molecular Medicine|December 22, 2025
Pi-pi stacking interactions with viral DNA contribute to the potency of naphthyridine-based HIV-1 integrase inhibitorsXue Zhi Zhao, Min Li, Steven J Smith, et al.
ACS Infectious Diseases|March 9, 2021
HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase MutantsSteven J Smith, Xue Zhi Zhao, Dario Oliveira Passos, et al.
Atmospheric Chemistry and Physics|November 18, 2020
Interannual variability and trends of combustion aerosol and dust in major continental outflows revealed by MODIS retrievals and CAM5 simulations during 2003-2017Hongbin Yu, Yang Yang, Hailong Wang, et al.
Pageof 10